Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Lactamases | 8 | 2016 | 34 | 1.940 |
Why?
|
| Acinetobacter baumannii | 3 | 2016 | 35 | 1.000 |
Why?
|
| Acinetobacter Infections | 3 | 2016 | 24 | 0.920 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2016 | 88 | 0.660 |
Why?
|
| DNA Transposable Elements | 2 | 2016 | 50 | 0.560 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2012 | 62 | 0.520 |
Why?
|
| Cross Infection | 3 | 2016 | 47 | 0.510 |
Why?
|
| Chromosomes, Bacterial | 1 | 2014 | 21 | 0.450 |
Why?
|
| Genotype | 2 | 2018 | 796 | 0.440 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 96 | 0.430 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 454 | 0.410 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 580 | 0.410 |
Why?
|
| Puerto Rico | 9 | 2016 | 1376 | 0.400 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2012 | 232 | 0.390 |
Why?
|
| beta-Lactam Resistance | 1 | 2009 | 4 | 0.320 |
Why?
|
| Acinetobacter | 1 | 2009 | 9 | 0.320 |
Why?
|
| Sequence Analysis, DNA | 4 | 2018 | 508 | 0.320 |
Why?
|
| Bacteria | 1 | 2011 | 285 | 0.280 |
Why?
|
| Gram-Positive Cocci | 2 | 2003 | 2 | 0.250 |
Why?
|
| Gastroenteritis | 1 | 2005 | 18 | 0.230 |
Why?
|
| Diarrhea | 1 | 2005 | 95 | 0.220 |
Why?
|
| Aged, 80 and over | 5 | 2016 | 2803 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2018 | 429 | 0.180 |
Why?
|
| Klebsiella pneumoniae | 2 | 2011 | 26 | 0.170 |
Why?
|
| Aged | 6 | 2016 | 7982 | 0.160 |
Why?
|
| Genome, Bacterial | 2 | 2018 | 132 | 0.150 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2012 | 34 | 0.140 |
Why?
|
| Gram-Negative Bacteria | 2 | 2011 | 27 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 62 | 0.130 |
Why?
|
| Humans | 12 | 2018 | 42163 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 65 | 0.130 |
Why?
|
| Gene Order | 1 | 2016 | 17 | 0.130 |
Why?
|
| Evolution, Molecular | 2 | 2018 | 299 | 0.130 |
Why?
|
| Genes, Bacterial | 1 | 2016 | 92 | 0.120 |
Why?
|
| Carbapenems | 3 | 2011 | 8 | 0.120 |
Why?
|
| Female | 7 | 2016 | 24018 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 4 | 2012 | 415 | 0.120 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 90 | 0.110 |
Why?
|
| Middle Aged | 5 | 2016 | 11819 | 0.100 |
Why?
|
| Hospitals, University | 2 | 2003 | 39 | 0.100 |
Why?
|
| Male | 6 | 2016 | 22779 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2012 | 46 | 0.090 |
Why?
|
| Pseudomonas Infections | 1 | 2012 | 23 | 0.090 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 15 | 0.090 |
Why?
|
| Automation | 1 | 2011 | 23 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1559 | 0.090 |
Why?
|
| Klebsiella Infections | 1 | 2010 | 11 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 169 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2009 | 245 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2011 | 461 | 0.070 |
Why?
|
| Mass Screening | 1 | 2011 | 531 | 0.070 |
Why?
|
| Infant | 2 | 2009 | 1143 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 1516 | 0.060 |
Why?
|
| Inpatients | 1 | 2005 | 78 | 0.050 |
Why?
|
| Hospitals, Private | 1 | 2003 | 6 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 42 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2003 | 13 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 28 | 0.050 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2003 | 20 | 0.050 |
Why?
|
| Adult | 3 | 2009 | 13458 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2003 | 97 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2005 | 960 | 0.050 |
Why?
|
| Child | 2 | 2009 | 3381 | 0.040 |
Why?
|
| Animals | 1 | 2016 | 16695 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2002 | 1574 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 58 | 0.030 |
Why?
|
| Adolescent | 2 | 2009 | 5950 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 33 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 602 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 27 | 0.020 |
Why?
|
| Porins | 1 | 2009 | 20 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2009 | 58 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 98 | 0.020 |
Why?
|
| United States | 1 | 2018 | 5072 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1266 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 3942 | 0.010 |
Why?
|
| Urban Population | 1 | 2003 | 364 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 2485 | 0.010 |
Why?
|